Table 2.
Comparison of the reproductive outcomes of the CC + letrozole and CC-alone groups
Outcome | Letrozole + CC | Clomiphene citrate | Absolute difference between groups (95% CI)a |
Rate ratio in combination group (95% CI)b |
P-values |
---|---|---|---|---|---|
Primary outcome | |||||
Ovulation, n (%) | |||||
Intention to treat analysis† | 39 (78) | 35 (70) |
8.0 (-9.1 to 24.6) |
1.11 (0.88 to 1.41) |
0.494 |
Per-protocol analysis‡ | 37 (77) | 33 (70) |
6.9 (-10.7 to 24.0) |
1.10 (0.86 to 1.40) |
0.447 |
Secondary outcomes | |||||
Pregnancy, n(%) | |||||
Conception | 3 (6.3) | 2 (4.3) |
2.0 (-8.8 to 13.0) |
1.47 (0.26 to 8.40) |
1.000 |
Clinical pregnancy | 1 | 2 | NA* | NA* | NA* |
Live birth | 1 | 1 | NA* | NA* | NA* |
Pregnancy loss | 2 | 1 | NA* | NA* | NA* |
Fecundity among those who ovulated | |||||
Conception | 3/37 | 2/33 |
2.0 (-12.5 to 15.9) |
1.34 (0.24 to 7.52) |
1.000 |
Clinical pregnancy | 1/37 | 2/33 | NA* | NA* | NA* |
Live birth | 1//37 | 1/33 | NA* | NA* | NA* |
† Letrozole + CC, n = 50; CC, n = 50
‡ Letrozole + CC, n = 48; CC, n = 47
a Differences are presented as percentages
b Differences are presented as ratio
NA* not applicable due to small sample